These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 2545179)

  • 1. Spurious elevation of plasma immunoreactive adrenocorticotropic hormone in cyclic Cushing's syndrome.
    Wickus GG; Pagliara AS; Caplan RH
    Arch Pathol Lab Med; 1989 Jul; 113(7):797-9. PubMed ID: 2545179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal and abnormal regulation of beta-msh in man.
    Abe K; Nicholson WE; Liddle GW; Orth DN; Island DP
    J Clin Invest; 1969 Aug; 48(8):1580-5. PubMed ID: 4307702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
    Castro M; Elias LL; Elias PC; Moreira AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An unusual profile of endocrine study in a patient with pre-Cushing's syndrome.
    Kodama C; Nakada T; Sasagawa I; Ishigooka M; Yamaguchi T; Suzuki H
    Int Urol Nephrol; 1993; 25(6):517-24. PubMed ID: 8175270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and treatment of Cushing's syndrome.
    Nieman LK; Ilias I
    Am J Med; 2005 Dec; 118(12):1340-6. PubMed ID: 16378774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
    Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
    J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated plasma 19-hydroxyandrostenedione levels in Cushing's disease: stimulation with ACTH and inhibition with metyrapone.
    Mune T; Morita H; Yasuda K; Murayama M; Yamakita N; Miura K
    Clin Endocrinol (Oxf); 1993 Mar; 38(3):265-72. PubMed ID: 8384536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease.
    Flitsch J; Knappe UJ; Lüdecke DK
    Zentralbl Neurochir; 2003; 64(1):6-11. PubMed ID: 12582940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of Cushing's syndrome due to bilateral multiple adrenal adenomas].
    Ashida S; Kataoka S; Yamasaki I; Yamashita M; Ohashi Y; Morioka M; Shuin T
    Hinyokika Kiyo; 1997 Aug; 43(8):567-70. PubMed ID: 9310779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ectopic Cushing's syndrome due to concurrent corticotropin-releasing hormone (CRH) and adrenocorticotropic hormone (ACTH) secreted by malignant gastrinoma.
    Park SY; Rhee Y; Youn JC; Park YN; Lee S; Kim DM; Song SY; Lim SK
    Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):13-6. PubMed ID: 17286228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRH in Cushing's syndrome.
    Müller OA; Stalla GK; von Werder K
    Horm Metab Res Suppl; 1987; 16():51-8. PubMed ID: 2832289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral and simultaneous sinus petrosus inferior catheterization in patients with Cushing's syndrome: plasma-immunoreactive-ACTH-concentrations before and after administration of CRF.
    Schulte HM; Allolio B; Günther RW; Benker G; Windeck R; Winkelmann W; Reinwein D
    Horm Metab Res Suppl; 1987; 16():66-7. PubMed ID: 2832295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of using basal plasma adrenocorticotropic hormone-radioimmunoassay (ACTH-RIA) level in the identification of the cause of Cushing's syndrome.
    Sriussadaporn S; Ploybutr S; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
    J Med Assoc Thai; 1997 Apr; 80(4):233-41. PubMed ID: 9175392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Test of pituitary adrenal restraining with IV dexamethasone in the diagnosis of Cushing's syndrome (author's transl)].
    Linquette M; Cappoen JP; Fourlinnie JC; Harpignies G
    Sem Hop; 1980 Sep 18-25; 56(33-36):1380-4. PubMed ID: 6252630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of adrenocorticotropin (ACTH) secretion in cyclic Cushing's syndrome: evidence for more than one abnormal ACTH biorhythm.
    Jordan RM; Ramos-Gabatin A; Kendall JW; Gaudette D; Walls RC
    J Clin Endocrinol Metab; 1982 Sep; 55(3):531-7. PubMed ID: 6284783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoassay of ACTH in plasma.
    Berson SA; Yalow RS
    J Clin Invest; 1968 Dec; 47(12):2725-51. PubMed ID: 4302180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma pregnenolone and 17-OH-pregnenolone in patients with adrenal tumors, ACTH excess, or idiopathic hirsutism.
    McKenna TJ; Miller RB; Liddle GW
    J Clin Endocrinol Metab; 1977 Feb; 44(2):231-6. PubMed ID: 190251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new immunoradiometric assay for corticotropin evaluated in normal subjects and patients with Cushing's syndrome.
    Raff H; Findling JW
    Clin Chem; 1989 Apr; 35(4):596-600. PubMed ID: 2539271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Paroxysmal ACTH secretion from an adrenal medullary tumour (author's transl)].
    Burmeister P; Simon A
    Dtsch Med Wochenschr; 1975 May; 100(20):1132-5. PubMed ID: 165054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.